uniQure N.V. (LON:0EE0)
23.20
-0.78 (-3.23%)
Feb 12, 2026, 5:07 PM GMT
uniQure Employees
uniQure had 209 employees as of December 31, 2024. The number of employees decreased by 271 or -56.46% compared to the previous year.
Employees
209
Change (1Y)
-271
Growth (1Y)
-56.46%
Revenue / Employee
56.07K GBP
Profits / Employee
-837.01K GBP
Market Cap
1.02B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 209 | -271 | -56.46% |
| Dec 31, 2023 | 480 | -21 | -4.19% |
| Dec 31, 2022 | 501 | 38 | 8.21% |
| Dec 31, 2021 | 463 | 131 | 39.46% |
| Dec 31, 2020 | 332 | 84 | 33.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Spire Healthcare Group | 15,703 |
| CVS Group | 8,850 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,780 |
uniQure News
- 6 days ago - Early uniQure Fabry Trial Shows Lasting Enzyme Boost, Safety Watch - Benzinga
- 6 days ago - Early uniQure Fabry Trial Shows Lasting Enzyme Boost, Safety Watch - Benzinga
- 6 days ago - uniQure (QURE) Shares Promising Data on Gene Therapy for Fabry Disease - GuruFocus
- 6 days ago - uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease - GlobeNewsWire
- 11 days ago - QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - PRNewsWire
- 13 days ago - QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - GlobeNewsWire
- 14 days ago - Alger Small Cap Focus Fund Q4 2025 Portfolio Update - Seeking Alpha
- 15 days ago - QURE Makes Notable Cross Below Critical Moving Average - Nasdaq